Which closed-end funds own Chinook Therapeutics Inc?
4 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $68.7K. Security type: common equity. Country: United States. CUSIP 169CVR016 · ISIN US169CVR0169.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| GDL GDL Fund | U.S. Equity | 0.01% | $12.8K | 64,000 sh | $122M | 21.3% discount | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.00% | $7.7K | 38,284 sh | $228M | NAV unavailable | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.00% | $18.9K | 59,063 sh | $690M | 3.4% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.00% | $29.4K | 91,800 sh | $1.4B | 7.1% discount | Jun 30, 2026 |
4 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: CONTRA CHINOOK THERAPE.
Issuer-level search for “CHINOOK THERAPEUTICS INC” → · Compare two funds’ portfolios →